The global Elotuzumab market size was valued at US$ 312.5 million in 2024 and is projected to reach US$ 456.8 million by 2030, at a CAGR of 6.5% during the forecast period 2024-2030.
United States Elotuzumab market size was valued at US$ 167.3 million in 2024 and is projected to reach US$ 240.2 million by 2030, at a CAGR of 6.2% during the forecast period 2024-2030.
Elotuzumab is a monoclonal antibody targeting SLAMF7, used in combination therapy for multiple myeloma.
Moderate growth driven by use in combination therapies for relapsed/refractory multiple myeloma. Increasing competition from other novel agents impacting market share. Ongoing clinical trials in new combinations potentially expanding market opportunities.
Report Overview
This report provides a deep insight into the global Elotuzumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Elotuzumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Elotuzumab market in any manner.
Global Elotuzumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Bristol Myers Squibb
- Abbvie
Market Segmentation (by Type)
- 300mg Injection
- 400mg Injection
Market Segmentation (by Application)
- Hospital
- Clinic
- Drug Center
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Elotuzumab Market
- Overview of the regional outlook of the Elotuzumab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Elotuzumab
1.2 Key Market Segments
1.2.1 Elotuzumab Segment by Type
1.2.2 Elotuzumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Elotuzumab Market Overview
2.1 Global Market Overview
2.1.1 Global Elotuzumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Elotuzumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Elotuzumab Market Competitive Landscape
3.1 Global Elotuzumab Sales by Manufacturers (2019-2024)
3.2 Global Elotuzumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Elotuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Elotuzumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Elotuzumab Sales Sites, Area Served, Product Type
3.6 Elotuzumab Market Competitive Situation and Trends
3.6.1 Elotuzumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Elotuzumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Elotuzumab Industry Chain Analysis
4.1 Elotuzumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Elotuzumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Elotuzumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Elotuzumab Sales Market Share by Type (2019-2024)
6.3 Global Elotuzumab Market Size Market Share by Type (2019-2024)
6.4 Global Elotuzumab Price by Type (2019-2024)
7 Elotuzumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Elotuzumab Market Sales by Application (2019-2024)
7.3 Global Elotuzumab Market Size (M USD) by Application (2019-2024)
7.4 Global Elotuzumab Sales Growth Rate by Application (2019-2024)
8 Elotuzumab Market Segmentation by Region
8.1 Global Elotuzumab Sales by Region
8.1.1 Global Elotuzumab Sales by Region
8.1.2 Global Elotuzumab Sales Market Share by Region
8.2 North America
8.2.1 North America Elotuzumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Elotuzumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Elotuzumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Elotuzumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Elotuzumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bristol Myers Squibb
9.1.1 Bristol Myers Squibb Elotuzumab Basic Information
9.1.2 Bristol Myers Squibb Elotuzumab Product Overview
9.1.3 Bristol Myers Squibb Elotuzumab Product Market Performance
9.1.4 Bristol Myers Squibb Business Overview
9.1.5 Bristol Myers Squibb Elotuzumab SWOT Analysis
9.1.6 Bristol Myers Squibb Recent Developments
9.2 Abbvie
9.2.1 Abbvie Elotuzumab Basic Information
9.2.2 Abbvie Elotuzumab Product Overview
9.2.3 Abbvie Elotuzumab Product Market Performance
9.2.4 Abbvie Business Overview
9.2.5 Abbvie Elotuzumab SWOT Analysis
9.2.6 Abbvie Recent Developments
10 Elotuzumab Market Forecast by Region
10.1 Global Elotuzumab Market Size Forecast
10.2 Global Elotuzumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Elotuzumab Market Size Forecast by Country
10.2.3 Asia Pacific Elotuzumab Market Size Forecast by Region
10.2.4 South America Elotuzumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Elotuzumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Elotuzumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Elotuzumab by Type (2025-2030)
11.1.2 Global Elotuzumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Elotuzumab by Type (2025-2030)
11.2 Global Elotuzumab Market Forecast by Application (2025-2030)
11.2.1 Global Elotuzumab Sales (Kilotons) Forecast by Application
11.2.2 Global Elotuzumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Elotuzumab Market Size Comparison by Region (M USD)
Table 5. Global Elotuzumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Elotuzumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Elotuzumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Elotuzumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Elotuzumab as of 2022)
Table 10. Global Market Elotuzumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Elotuzumab Sales Sites and Area Served
Table 12. Manufacturers Elotuzumab Product Type
Table 13. Global Elotuzumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Elotuzumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Elotuzumab Market Challenges
Table 22. Global Elotuzumab Sales by Type (Kilotons)
Table 23. Global Elotuzumab Market Size by Type (M USD)
Table 24. Global Elotuzumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Elotuzumab Sales Market Share by Type (2019-2024)
Table 26. Global Elotuzumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Elotuzumab Market Size Share by Type (2019-2024)
Table 28. Global Elotuzumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Elotuzumab Sales (Kilotons) by Application
Table 30. Global Elotuzumab Market Size by Application
Table 31. Global Elotuzumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Elotuzumab Sales Market Share by Application (2019-2024)
Table 33. Global Elotuzumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Elotuzumab Market Share by Application (2019-2024)
Table 35. Global Elotuzumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Elotuzumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Elotuzumab Sales Market Share by Region (2019-2024)
Table 38. North America Elotuzumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Elotuzumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Elotuzumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Elotuzumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Elotuzumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol Myers Squibb Elotuzumab Basic Information
Table 44. Bristol Myers Squibb Elotuzumab Product Overview
Table 45. Bristol Myers Squibb Elotuzumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol Myers Squibb Business Overview
Table 47. Bristol Myers Squibb Elotuzumab SWOT Analysis
Table 48. Bristol Myers Squibb Recent Developments
Table 49. Abbvie Elotuzumab Basic Information
Table 50. Abbvie Elotuzumab Product Overview
Table 51. Abbvie Elotuzumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Abbvie Business Overview
Table 53. Abbvie Elotuzumab SWOT Analysis
Table 54. Abbvie Recent Developments
Table 55. Global Elotuzumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Elotuzumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Elotuzumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Elotuzumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Elotuzumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Elotuzumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Elotuzumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Elotuzumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Elotuzumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Elotuzumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Elotuzumab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Elotuzumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Elotuzumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Elotuzumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Elotuzumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Elotuzumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Elotuzumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Elotuzumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Elotuzumab Market Size (M USD), 2019-2030
Figure 5. Global Elotuzumab Market Size (M USD) (2019-2030)
Figure 6. Global Elotuzumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Elotuzumab Market Size by Country (M USD)
Figure 11. Elotuzumab Sales Share by Manufacturers in 2023
Figure 12. Global Elotuzumab Revenue Share by Manufacturers in 2023
Figure 13. Elotuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Elotuzumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Elotuzumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Elotuzumab Market Share by Type
Figure 18. Sales Market Share of Elotuzumab by Type (2019-2024)
Figure 19. Sales Market Share of Elotuzumab by Type in 2023
Figure 20. Market Size Share of Elotuzumab by Type (2019-2024)
Figure 21. Market Size Market Share of Elotuzumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Elotuzumab Market Share by Application
Figure 24. Global Elotuzumab Sales Market Share by Application (2019-2024)
Figure 25. Global Elotuzumab Sales Market Share by Application in 2023
Figure 26. Global Elotuzumab Market Share by Application (2019-2024)
Figure 27. Global Elotuzumab Market Share by Application in 2023
Figure 28. Global Elotuzumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Elotuzumab Sales Market Share by Region (2019-2024)
Figure 30. North America Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Elotuzumab Sales Market Share by Country in 2023
Figure 32. U.S. Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Elotuzumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Elotuzumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Elotuzumab Sales Market Share by Country in 2023
Figure 37. Germany Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Elotuzumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Elotuzumab Sales Market Share by Region in 2023
Figure 44. China Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Elotuzumab Sales and Growth Rate (Kilotons)
Figure 50. South America Elotuzumab Sales Market Share by Country in 2023
Figure 51. Brazil Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Elotuzumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Elotuzumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Elotuzumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Elotuzumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Elotuzumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Elotuzumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Elotuzumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Elotuzumab Sales Forecast by Application (2025-2030)
Figure 66. Global Elotuzumab Market Share Forecast by Application (2025-2030)
